SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-001904
Filing Date
2019-01-24
Accepted
2019-01-24 17:29:52
Documents
2
Period of Report
2019-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1548
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4120
  Complete submission text file 0000899243-19-001904.txt   7046
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
Cohen Fred E (Reporting) CIK: 0001339358 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 19540718

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences